Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
HPGC Renmintongtai Pharmaceutical Corporation on 6ix
Earlier from HPGC Renmintongtai Pharmaceutical
- Announcement on Outline of Performance and Cash Dividend Briefing for 2025 and Q1 2026
- Announcement on Convening the 2025 Annual and Q1 2026 Performance and Cash Dividend Briefing
- Report for Q1 2026
- Announcement on Confirming Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan
- Announcement on Expiration of Shareholding Reduction Plan for Controlling Shareholders and Results of Shareholding Reduction
Later from HPGC Renmintongtai Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resolutions of the 10th Meeting of the 11th Board of Directors
- Announcement on Adjusting Members of Special Committees of the Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 12th Meeting of the 11th Board of Directors
Follow HPGC Renmintongtai Pharmaceutical into a list and get an email when it puts out news.
Follow HPGC Renmintongtai Pharmaceutical